Randomized, Comparative, Double-Blind, Placebo-Controlled, Triple-Dummy, Four-Way Cross-Over Study to Investigate Neurocognitive Effects of Brivaracetam in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Brivaracetam (Primary) ; Levetiracetam; Lorazepam
- Indications Epilepsy; Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacodynamics
- Sponsors UCB
- 26 Oct 2008 Trial end date changed from 1 Sep 2008 to 1 Oct 2008 as reported by Clinicaltrials.gov.
- 26 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History